Related Experiment Video
Updated: Sep 25, 2025

05:30
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
631
Targeted Mass Spectrometry-Based Proteomics Method to Quantify Placental Extracellular Vesicles.
Andrew Lai1, Carlos Palma1, Alexis Salas2
1Exosome Biology Laboratory, University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital, The University of Queensland, Brisbane, QLD, Australia.
Methods in Molecular Biology (Clifton, N.J.)
|April 25, 2022
Summary
Quantifying placental extracellular vesicles (EVs) in maternal blood is now possible. This breakthrough uses placental-type alkaline phosphatase (PLAP) as a marker, enabling new research into pregnancy complications.
Area of Science:
- Reproductive biology
- Biochemistry
- Molecular biology
Background:
- Extracellular vesicles (EVs) are crucial intercellular communicators, carrying proteins, RNA, and DNA.
- Placental EVs appear in maternal circulation early in gestation and increase with gestational age.
- Quantifying placental EVs in maternal blood is essential for understanding pregnancy but has been a significant challenge.
Purpose of the Study:
- To develop and describe a method for quantifying placental EVs in maternal circulation.
- To utilize placental-type alkaline phosphatase (PLAP) as a specific marker for placental EVs.
- To overcome previous limitations in tracking placental EV dynamics during pregnancy.
Main Methods:
- Development of a targeted proteomics workflow.
- Selection of specific peptides derived from the PLAP protein for quantification.
- Application of the method to maternal circulation samples.
Main Results:
- Demonstrated the presence of PLAP EVs specifically in pregnant women's blood.
- Established a quantifiable workflow for placental EVs using PLAP as a marker.
- Provided a means to measure placental EV concentration in maternal circulation.
Conclusions:
- Placental-type alkaline phosphatase (PLAP) is a reliable marker for identifying placental EVs in maternal blood.
- The described targeted proteomics approach enables the quantification of placental EVs.
- This methodology opens new avenues for studying normal and complicated pregnancies through EV analysis.
Keywords:
Multiple reaction monitoring high resolution (MRMHR)Placental alkaline phosphatase (PLAP)Placental extracellular vesiclesTargeted mass spectrometry
